Amber Bio
San Francisco
About Amber Bio
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $26.0M
- Funding stage: Seed
- Last round: Seed (Aug 2023)
- Website: amber.bio
- Phone: +1 761 - 88 01 43
Industries & Categories
Biotechnology, Genetics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amber-bio-80125 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.